Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

748692

registered interest
date	05/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neurology: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the number of interventional neuroradiologists in England; and whether he plans to increase that number.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	3022
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>Health Education England (HEE) is responsible for the planning and funding of post-registration medical education. HEE works directly with a number of partners, including National Health Service trusts, to assess demand and supply for clinical staff, and commissions programmes of education accordingly. HEE’s investment in training reflects the relative priorities the NHS and HEE have to develop the future workforce, including Radiology.</p><p> </p><p>HEE is working with the Royal College of Radiologists and other stakeholders to explore options for developing the necessary competencies in Interventional Radiology specialists, including those who currently do not have the required Interventional Neuroradiology experience; including Neurosurgeons and Cardiologists.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/07/2017 12:41:11 answering member 1542 label Biography information for Philip Dunne
tabling member	18 label Biography information for Dame Cheryl Gillan

748693

registered interest
date	05/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the announcement by NHS England of 11 April 2017 on mechanical thrombectomy, what estimate he has made of the savings in long-term health and social care costs from those stroke patients who receive a mechanical thrombectomy each year.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	3249
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>NHS England agreed to fund thrombectomy for stroke in April 2017.</p><p>Progression to full implementation will need to take place on a phased basis to ensure the service providers can put in place the necessary staffing and working arrangements. In the short term there will be an interim set of arrangements.</p><p>Initially the procedure will be undertaken in neuroscience centres which are currently being assessed to ensure that they meet the standards set out in the service specification that is currently out for public consultation. This information will be used by a national oversight group and regional commissioning teams to assess who is able to provide the service in this interim period and will not be published. Further work with the providers of this service will be completed with regional commissioners and the services directly to establish clear action plans which will lead to full implementation.</p><p>It is anticipated that there will be some 1,000 cases completed by the end of March 2018; and that, by 2023, about 10% of stroke admissions in England (8,000 cases) will be treated with thrombectomy annually. NHS England have not undertaken an independent cost benefit analysis of thrombectomy but there have been research studies published such as Jean Ganesalingam et al – “Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers”, in Acute Ischemic Stroke 2015;46:2591-2598. This showed that it is a highly cost effective treatment, particularly when the longer term health and social care costs are taken into account.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 3250 3251 question first answered 13/07/2017 13:02:42 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

748694

registered interest
date	05/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the announcement by NHS England of 11 April 2017 on mechanical thrombectomy, when the assessment of the readiness of each of the 24 neuroscience centres to carry out mechanical thrombectomy will be completed; and whether the results of this assessment will be published.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	3250
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>NHS England agreed to fund thrombectomy for stroke in April 2017.</p><p>Progression to full implementation will need to take place on a phased basis to ensure the service providers can put in place the necessary staffing and working arrangements. In the short term there will be an interim set of arrangements.</p><p>Initially the procedure will be undertaken in neuroscience centres which are currently being assessed to ensure that they meet the standards set out in the service specification that is currently out for public consultation. This information will be used by a national oversight group and regional commissioning teams to assess who is able to provide the service in this interim period and will not be published. Further work with the providers of this service will be completed with regional commissioners and the services directly to establish clear action plans which will lead to full implementation.</p><p>It is anticipated that there will be some 1,000 cases completed by the end of March 2018; and that, by 2023, about 10% of stroke admissions in England (8,000 cases) will be treated with thrombectomy annually. NHS England have not undertaken an independent cost benefit analysis of thrombectomy but there have been research studies published such as Jean Ganesalingam et al – “Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers”, in Acute Ischemic Stroke 2015;46:2591-2598. This showed that it is a highly cost effective treatment, particularly when the longer term health and social care costs are taken into account.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 3249 3251 question first answered 13/07/2017 13:02:42 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

748695

registered interest
date	05/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the announcement by NHS England of 11 April 2017 on mechanical thrombectomy, when NHS England will start to commission mechanical thrombectomy; when it is planned that the first 1,000 patients will be refitted from mechanical thrombectomy; and when it is planned that 8,000 patients a year will be benefitting from mechanical thrombectomy.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	3251
answer	answer is ministerial correction date of answer 13/07/2017 answer text <p>NHS England agreed to fund thrombectomy for stroke in April 2017.</p><p>Progression to full implementation will need to take place on a phased basis to ensure the service providers can put in place the necessary staffing and working arrangements. In the short term there will be an interim set of arrangements.</p><p>Initially the procedure will be undertaken in neuroscience centres which are currently being assessed to ensure that they meet the standards set out in the service specification that is currently out for public consultation. This information will be used by a national oversight group and regional commissioning teams to assess who is able to provide the service in this interim period and will not be published. Further work with the providers of this service will be completed with regional commissioners and the services directly to establish clear action plans which will lead to full implementation.</p><p>It is anticipated that there will be some 1,000 cases completed by the end of March 2018; and that, by 2023, about 10% of stroke admissions in England (8,000 cases) will be treated with thrombectomy annually. NHS England have not undertaken an independent cost benefit analysis of thrombectomy but there have been research studies published such as Jean Ganesalingam et al – “Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers”, in Acute Ischemic Stroke 2015;46:2591-2598. This showed that it is a highly cost effective treatment, particularly when the longer term health and social care costs are taken into account.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 3249 3250 question first answered 13/07/2017 13:02:43 answering member 4067 label Biography information for Steve Brine
tabling member	18 label Biography information for Dame Cheryl Gillan

748181

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Autism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Independent Mental Health Taskforce report entitled Five Year Forward View on Mental Health published in February 2016, what the timetable is for the establishment of a care pathway for autism.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	2861
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>An indicative timeline for the development of care pathways was set out in the Five Year Forward View for Mental Health. The precise timetable for the establishment of a care pathway for autism will be confirmed by NHS England in due course.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 10/07/2017 13:38:37 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	18 label Biography information for Dame Cheryl Gillan

712465

registered interest
date	20/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Learning Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding was allocated by NHS England to the learning disability GP annual health check scheme in 2015-16.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	68449
answer	answer is ministerial correction date of answer 23/03/2017 answer text <p>In 2015/16, spend on General Practitioner Learning Disabilities Directed Enhanced Services (DES) was £12.376 million. Under the DES, patients aged 14 and over with learning disabilities are offered an annual health check, which includes producing a health action plan.</p><p> </p><p>The National Audit Office has recently estimated that the annual cost of supporting a person with challenging behaviour and learning disabilities, autism or both within an assessment and treatment unit is £180,000.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 68446 question first answered 23/03/2017 17:13:36 answering member 4080 label Biography information for David Mowat
tabling member	18 label Biography information for Dame Cheryl Gillan

712466

registered interest
date	20/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Learning Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate he has made of the average annual cost to the public purse of supporting a person with challenging behaviour and learning disabilities, autism or both within an assessment and treatment unit.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	68446
answer	answer is ministerial correction date of answer 23/03/2017 answer text <p>In 2015/16, spend on General Practitioner Learning Disabilities Directed Enhanced Services (DES) was £12.376 million. Under the DES, patients aged 14 and over with learning disabilities are offered an annual health check, which includes producing a health action plan.</p><p> </p><p>The National Audit Office has recently estimated that the annual cost of supporting a person with challenging behaviour and learning disabilities, autism or both within an assessment and treatment unit is £180,000.</p> answering member constituency Warrington South answering member printed David Mowat grouped question UIN 68449 question first answered 23/03/2017 17:13:36 answering member 4080 label Biography information for David Mowat
tabling member	18 label Biography information for Dame Cheryl Gillan

674848

registered interest
date	18/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what policy proposals the Clinical Priority Advisory Group assigned priority level (a) 1, (b) 2, (c) 3, (d) 4 and (e) 5 to the specialised commissioning re-prioritisation process for 2016-17, announced on 4 December 2016.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	60527
answer	answer is ministerial correction date of answer 26/01/2017 answer text <p>Information on the annual prioritisation process for specialised treatments was announced by NHS England on 4 December 2016. This can be found here:</p><p> </p><p><a href="https://www.england.nhs.uk/2016/12/hiv-prevention-pregramme/" target="_blank">https://www.england.nhs.uk/2016/12/hiv-prevention-pregramme/</a></p><p> </p><p>The final outcomes of the 2016-17 prioritisation were as follows:</p><p> </p><table><tbody><tr><td><p>Recommended for routine commissioning</p></td><td><p>Not recommended for routine commissioning</p></td></tr><tr><td><p>- Pegvisomant for acromegaly as a third-line treatment for adults</p></td><td><p>- Eculizumab for treatment of recurrence of C3 glomerulopathy post-transplant</p></td></tr><tr><td><p>- Auditory brainstem implants for congenital abnormalities of the auditory nerves or cochleae</p></td><td><p>- Riociguat for pulmonary arterial hypertension</p></td></tr><tr><td><p>- Haematopoietic stem cell transplant for Lymphoplasmacytic lymphoma /Waldenstrom’s Macroglobulinaemia (adults)</p></td><td><p>- Second allogeneic haematopoietic stem cell transplant for relapsed disease</p></td></tr><tr><td><p>- Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex</p></td><td><p> </p></td></tr><tr><td><p>- Rituximab for immunoglobulin-G4 related disease (IgG4-RD)</p></td><td><p> </p></td></tr><tr><td><p>- Microprocessor controlled prosthetic knees</p></td><td><p> </p></td></tr><tr><td><p>- Tolvaptan for hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) for patients who require cancer chemotherapy</p></td><td><p> </p></td></tr><tr><td><p>- Ivacaftor for children (2-5 years) with cystic fibrosis (named mutations)</p></td><td><p> </p></td></tr><tr><td><p>- Sodium oxybate for symptom control for narcolepsy with cataplexy (children)</p></td><td><p> </p></td></tr><tr><td><p>- Pasireotide for Cushing’s Disease</p></td><td><p> </p></td></tr></tbody></table> answering member constituency Warrington South answering member printed David Mowat question first answered 26/01/2017 11:25:02 answering member 4080 label Biography information for David Mowat
tabling member	18 label Biography information for Dame Cheryl Gillan

674850

registered interest
date	18/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the timetable is for the NHS England 2018-19 specialised commissioning annual prioritisation process; and if he will make a statement.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	60526
answer	answer is ministerial correction date of answer 26/01/2017 answer text <p>NHS England expects to publish its prioritisation decisions for specialised services for the financial year 2017/18 in the spring of 2017.</p><p> </p><p>Clinical policy propositions that were not funded on grounds of affordability in the 2016/17 prioritisation round will have the opportunity to be considered again alongside new proposals being put forward for prioritisation in 2017/18.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 26/01/2017 10:49:03 answering member 4080 label Biography information for David Mowat
tabling member	18 label Biography information for Dame Cheryl Gillan

655692

registered interest
date	09/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Autism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that the autism referral to treatment pathway announced in the Five Year Forward View on Mental Health is being developed; and for what reasons it was not included in NHS England's implementation plan for the Five Year Forward View.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	56882
answer	answer is ministerial correction date of answer 14/12/2016 answer text <p>NHS England’s Implementation Plan for the Five Year Forward View for Mental Health was published in July 2016. It described the national programme of work that will be taken forward to deliver the recommendations of the Mental Health Task Force. This will include work to develop an evidence based treatment pathway for people who have co-occurring mental health needs and neurodevelopmental conditions such as autism. In parallel, the Department plans to work with partners to improve tracking of referral to assessment times for an autism diagnosis.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 14/12/2016 16:50:03 answering member 4080 label Biography information for David Mowat
tabling member	18 label Biography information for Dame Cheryl Gillan